Heart Research Centre and Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia.
J Cardiopulm Rehabil Prev. 2013 May-Jun;33(3):160-7. doi: 10.1097/HCR.0b013e318283927f.
Research demonstrates that depression at the time of a cardiac event predicts early mortality. However, the best time for depression screening is unknown. We investigated the prognostic importance of inhospital and 2-month depressive symptoms in predicting 12-year mortality in female cardiac patients.
A consecutive series of 170 women admitted to hospital after acute myocardial infarction or for coronary artery bypass graft surgery completed the Hospital Anxiety and Depression Scale inhospital and 2 months later. Hospital Anxiety and Depression Scale's depression subscale scores of 4 to 7 were classified as "mild" depressive symptoms and 8+ as "moderate/severe" depressive symptoms. Mortality was tracked through the Australian National Death Index and other sources.
: One hundred sixty-three (96%) of the 170 women were successfully tracked after 12 years. Of these women, 136 (83%) completed the depression subscale of the Hospital Anxiety and Depression Scale at both assessments and were included in the analyses. Over 12 years, 45 (33%) women died. Using logistic regression and controlling for age, disease severity, and diabetes, mild inhospital depression predicted mortality (P = .02), whereas moderate/severe inhospital depression did not (P = .14). At 2 months, moderate/severe depression predicted mortality (P = .05), whereas mild depression did not (P = .09). Half the patients (49%) changed depression class by the 2-month assessment. The death rate was highest (64%) in those whose mild inhospital depressive symptoms increased to moderate/severe and lowest (14%) in those whose moderate/severe inhospital symptoms remitted.
Mild inhospital depression and moderate/severe 2-month depression were predictive of 12-year deaths. The findings suggest a prognostic benefit in undertaking repeat depression screening 2 months after an acute cardiac event.
研究表明,心脏病发作时的抑郁预测早期死亡率。然而,尚不清楚进行抑郁筛查的最佳时间。我们研究了住院期间和 2 个月时的抑郁症状对预测女性心脏患者 12 年死亡率的预后重要性。
连续纳入 170 例急性心肌梗死或冠状动脉旁路移植术后住院的女性患者,在住院期间和 2 个月后完成医院焦虑抑郁量表(Hospital Anxiety and Depression Scale)。将医院焦虑抑郁量表抑郁分量表评分为 4 至 7 分的患者归类为“轻度”抑郁症状,8 分及以上为“中度/重度”抑郁症状。通过澳大利亚国家死亡索引和其他来源跟踪死亡率。
170 例女性患者中有 163 例(96%)在 12 年后成功追踪。在这些女性中,136 例(83%)在两次评估时均完成了医院焦虑抑郁量表的抑郁分量表,并纳入分析。在 12 年期间,有 45 例(33%)女性死亡。使用逻辑回归并控制年龄、疾病严重程度和糖尿病后,轻度住院时抑郁预测死亡率(P=0.02),而中度/重度住院时抑郁则无预测作用(P=0.14)。在 2 个月时,中度/重度抑郁预测死亡率(P=0.05),而轻度抑郁则无预测作用(P=0.09)。有一半的患者(49%)在 2 个月评估时改变了抑郁类型。轻度住院时抑郁症状加重为中度/重度的患者死亡率最高(64%),而中度/重度住院时症状缓解的患者死亡率最低(14%)。
轻度住院时抑郁和中度/重度 2 个月时抑郁是 12 年死亡的预测因素。这些发现表明,在急性心脏事件后 2 个月重复进行抑郁筛查具有预后益处。